AVITA Medical, Inc. (RCEL) stock
RCELNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as AVHHL
$15.77+0.55 (+3.61%)
Close on Nov 17, 2026Market cap $487.72MP/E –Yield –
AVITA Medical revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
AVITA Medical's revenue for the twelve months ending Jun 30, 2026 was $75.63M, up 1.0% year over year. For fiscal 2025 it was $71.61M, up 11.5% from the year before. The highest annual figure on record is $71.61M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $71.61M | +11.5% |
| FY2024 | Dec 31, 2024 | $64.25M | +28.1% |
| FY2023 | Dec 31, 2023 | $50.14M | +71.5% |
| FY2021 | Jun 30, 2021 | $29.23M | +104.9% |
| FY2020 | Jun 30, 2020 | $14.26M | +160.6% |
| FY2019 | Jun 30, 2019 | $5.47M | +489.2% |
| FY2018 | Jun 30, 2018 | $929.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $21.70M | +17.8% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $19.25M | +4.0% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $17.62M | -4.3% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $17.06M | -12.7% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $18.42M | +21.2% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $18.51M | +66.7% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $18.41M | +29.7% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $19.55M | +43.2% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $15.20M | +29.3% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $11.10M | +5.3% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $14.20M | +37.8% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $13.65M | +55.7% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $11.75M | +130.3% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $10.55M | +108.5% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $10.30M | +165.8% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $8.77M | +126.1% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $5.10M | +56.6% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $5.06M | +55.7% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $3.88M | +57.9% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $3.88M | +126.7% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $3.26M | +213.4% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $3.25M | +1108.2% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $2.46M | – |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $1.71M | – |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $1.04M | – |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $269.00K | – |
See a number that looks wrong?